All News

Lynch syndrome – a hereditary condition that increases a person’s risk for developing several types of cancer – is common among people with microsatellite instability-high (MSI-H) tumors, linking it to several new cancer types, according to large genomic study results presented at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting.

Pain management or cost management? Which local surgical anesthetic will your hospital use?

Age shouldn't be a determining factor in giving a patient with melanoma immunotherapy. In fact, one study found that older patients actually do better on checkpoint blockades.

Maybe Father's Day is a good day to encourage the men we care for to have those important checkups.

In the Keynote-042 trial, researchers found a four- to eight-month overall survival benefit among patients with non-small cell lung cancer (NSCLC), which was correlated with higher levels of PD-L1 expression, however, further study is warranted.

The FDA has granted an accelerated approval to Keytruda (pembrolizumab) for the treatment of adult and pediatric patients with refractory primary mediastinal large B-cell lymphoma (PMBCL), or those who have relapsed after 2 or more prior lines of therapy.

You may have noticed I haven’t posted a blog lately. It could only mean one of two things: I ran out of things to say or, it’s gardening season. As my family is sure to attest, the former is impossible.

The Food and Drug Administration approved a combination of Avastin (bevacizumab) plus the chemotherapy agents carboplatin and paclitaxel, followed by Avastin alone, for the treatment of patients with advanced ovarian cancer who have had surgical resection.

Part two of three in a series about my experiences at Relay for Life 2018

Nearly 20 percent of hematopoietic stem cell transplant (HSCT) survivors reported using cannabis, not just to ease physical and emotional side effects, but in the hopes that it would help treat their cancer, according to patient survey results presented at the 2018 of American Society of Clinical Oncology (ASCO) Annual Meeting.

The application is seeking approval for GARDASIL 9 to be used in women and men aged 27 to 45 years for the prevention of certain cancers and diseases caused by the nine human papillomavirus (HPV) types covered by the vaccine.

The Food and Drug Administration approved Keytruda (pembrolizumab) for the treatment of certain patients with cervical cancer.

In a presentation at the 2018 ASCO Annual Meeting, researchers from Kaiser Permanente also found that women were almost twice as likely to die from the disease compared with non-cancer deaths.

Breast cancer survivor grieves the loss of her mom to metastatic breast cancer and considers how she keeps deceased loved ones in her heart.

A male breast cancer survivor shares his most important tip.

The Food and Drug Administration (FDA) approved the supplemental New Drug Application to add to the U.S. Prescribing Information for Kyprolis (carfilzomib) for the treatment of patients with relapsed or refractory multiple myeloma.

How I escaped from cancer as a kid.

The FDA approved the Paxman Scalp Cooling System for patients with solid tumors who wish to prevent chemotherapy-related hair loss.

Part one of a three part series about my experiences about Relay for Life 2018

Being a survivor and patient advocate means keeping up to date with the latest in treatment options and hearing the latest news in cancer research. ASCO is the perfect conference for just that.

Recognize birthdays, but most importantly, keep hope, says a breast cancer and melanoma survivor.

What are important considerations for hurricane preparedness when undergoing cancer treatment?

A breast cancer survivor's thoughts on her eight-year cancerversary.

My research revealed some surprising findings. What can we do to fix this?

Cancer affects many aspects of a person’s life, such as the overall quality of their day-to-day living, but what if a person didn’t have the full-blown disease already? Could a precursor or asymptomatic stage of the disease still burden them?

None of us are perfect. We all have flaws and imperfections, some us more than others.

The Food and Drug Administration (FDA) approved Venclexta (venetoclax) in combination with Rituxan (rituximab) for the treatment of patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), with or without the genetic mutation 17p deletion, who have received at least one prior therapy.

How not being a writer and still writing helped me through cancer and cancer treatment.